TB fight making progress, but more funds needed, WHO reports

October 17, 2012 by Naomi Seck

The war on tuberculosis is getting new weapons for the first time in decades, offering hope for controlling the deadly disease but major funding shortfalls threaten progress, the World Health Organization said Wednesday.

"We are at a crossroads between the elimination of TB within our lifetime, possibly, and millions of avoidable deaths in the next several years," Mario Raviglione, director of the WHO Stop TB Department emphasized at a press conference in Washington as the WHO released its annual report.

The choice, said Kenneth Castro, of the US Centers for Disease Control and Prevention, at the same press conference, is to "pay now, or pay more later."

The WHO has pledged to cut TB deaths to half the 1990 rate, a goal the agency said in its new report it was on track to achieve in most regions. The number of new cases per capita had also fallen—down 2.2 percent in 2011 from the year before.

Nevertheless, tuberculosis remains one of the world's top killers: in 2011, there were some 8.7 million new cases around the world, causing 1.4 million deaths, according to the new report.

And the epidemic of multi-drug-resistant tuberculosis remains a monumental challenge, Raviglione said.

In 2012, only about one in five of those estimated to have the TB strains resistant to standard medications were officially diagnosed as such, the report revealed. In China and India, that figure was even worse: fewer than one in 10 drug resistant cases were detected.

This is a critical problem, explained Anthony Fauci, director of the US National Institutes of Health allergy and infectious diseases arm, also at the press conference.

"One of the major reasons for the development of multiple-drug-resistant TB is inadequate treatment of plain old garden variety TB," Fauci told reporters.

"And one of the most important inciters of extensively drug resistant TB is inadequate treatment of multiple-drug-resistant TB."

But hope for wresting better control of the drug-resistant strains is rising thanks to a relatively new and inexpensive tool that allows for rapid diagnosis in a lab, in under two hours.

Some 67 developing countries, led by South Africa, are rolling out the molecular test, whose price has dropped by nearly half to $10 in the space of just a few months.

Equally exciting are two new drugs, on a path to be approved by the US and Europe for use in patients by next year.

The drugs—the first new TB medications in over forty years—were developed using high-tech analyses of the bacillus that causes tuberculosis, making them the first ever designed specifically for the treatment of the lung disease, he explained.

And as many as a dozen new vaccine candidates are in development to replace the imperfect one currently used.

Medical aid group Medicins Sans Frontiers agreed the new tools are promising, but said more must be done.

The WHO report "reinforces that multidrug-resistant tuberculosis is an escalating public health emergency," the group's TB advisor Grania Brigden said in a statement.

"Yet the global response is abysmal, with levels of testing and treatment remaining shockingly low," she said, adding that, even when diagnosed, the survival rate of multi-drug-resistant TB is less than 50 percent.

"We continue to struggle every day with inadequate tools and drugs to tackle the disease," which is increasing in prevalence in the places they work, she said.

Medical journal "The Lancet" was similarly frustrated, arguing in an editorial published to coincide with the WHO report that "insufficient attention and funding over several decades have allowed the global epidemic to remain a deep scar on the reputation of global health."

The WHO said it is $3 billion short of the $8 billion it needs to implement its plans to treat and control TB next year. And it has only a third of the $2 billion needed required for research and development.

"If the gaps are not filled ... we are going to see and we have to accept millions of deaths," from tuberculosis in the coming years, Raviglione warned.

"We will not have a decline in incidence. We will not be able to say elimination is possible in some settings, because the incidence will stabilize and probably grow again."

Explore further: Tuberculosis cases decline worldwide: WHO

Related Stories

Tuberculosis cases decline worldwide: WHO

October 11, 2011
For the first time on record, fewer people worldwide are getting sick from tuberculosis, but cash is short in the fight against drug-resistant forms of the disease, the World Health Organization said Tuesday.

China faces 'serious' epidemic of drug-resistant TB (Update)

June 6, 2012
China faces a "serious epidemic" of drug-resistant tuberculosis according to the first-ever nationwide estimate of the size of the problem there, said a US-published study on Wednesday.

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.